Gender effects on humoral immune responses to smallpox vaccine

Vaccine

Volumn 27, Issue 25-26, 2009, Pages 3319-3323

  Kennedy, Richard B ^a   Ovsyannikova, Inna G ^a   Pankratz, V Shane ^a   Vierkant, Robert A ^a   Jacobson, Robert M ^a   Ryan, Margaret A K ^b   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

Neutralizing antibody; Smallpox vaccine; Vaccine response; Vaccinia

Indexed keywords

BETA GALACTOSIDASE; NEUTRALIZING ANTIBODY; SMALLPOX VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DILUTION; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SINGLE DRUG DOSE; SMALLPOX; VACCINIA VIRUS; VIRUS EXPRESSION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; FEMALE; HUMANS; MALE; NEUTRALIZATION TESTS; SEX CHARACTERISTICS; SMALLPOX VACCINE; VACCINATION;

EID: 67249108642     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.086     Document Type: Article

References (33)

1. Fenner F. Smallpox and its Eradication vol. xvi (1988), World Health Organization, Geneva p. 1460
2. Fulginiti V.A., Papier A., Lane J.M., Neff J.M., and Henderson D.A. Smallpox vaccination: a review. Part II Adverse events. Clin Infect Dis 37 2 (2003) 251-271
3. Arness M.K., Eckart R.E., Love S.S., Atwood J.E., Wells T.S., Engler R.J., et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA 289 24 (2003) 3283-3289
4. Henderson D.A., Inglesby T.V., Bartlett J.G., Ascher M.S., Eitzen E., Jahrling P.B., et al. Smallpox as a biological weapon: medical and public health management. JAMA 281 22 (1999) 2127-2137
5. Belyakov I.M., Earl P., Dzutsev A., Kuznetsov V.A., Lemon M., Wyatt L.S., et al. Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc Natl Acad Sci USA 100 16 (2003) 9458-9463
6. Xu R., Johnson A.J., Liggitt D., and Bevan M.J. Cellular and humoral immunity against vaccinia virus infection of mice. J Immunol 172 10 (2004) 6265-6271
7. Panchanathan V., Chaudhri G., and Karupiah G. Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function. J Virol 80 13 (2006) 6333-6338
8. Thio C.L., Thomas D.L., Goedert J.J., Vlahov D., Nelson K.E., Hilgartner M.W., et al. Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis 184 1 (2001) 16-21
9. Zabaleta J., Schneider B.G., Ryckman K., Hooper P.F., Camargo M.C., Piazuelo M.B., et al. Ethnic differences in cytokine gene polymorphisms: potential implications for cancer development. Cancer Immunol Immunother 57 1 (2008) 107-114
10. Mayr F.B., Spiel A.O., Leitner J.M., Firbas C., Kliegel T., and Jilma B. Ethnic differences in plasma levels of interleukin-8 (IL-8) and granulocyte colony stimulating factor (G-CSF). Transl Res 149 1 (2007) 10-14
11. Dhiman N., Ovsyannikova I.G., Vierkant R.A., Pankratz V.S., Jacobson R.M., and Poland G.A. Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population. Tissue Antigens 72 3 (2008) 211-220
12. de la C.S.B., Kouri G., and Guzman M.G. Race: a risk factor for dengue hemorrhagic fever. Arch Virol 152 3 (2007) 533-542
13. Domínguez A., Plans P., Costa J., Torner N., Cardenosa N., Batalla J., et al. Seroprevalence of measles, rubella, and mumps antibodies in Catalonia Spain: results of a cross-sectional study. Eur J Clin Microbiol Infect Dis 25 5 (2006) 310-317
14. Ovsyannikova I.G., Jacobson R.M., Dhiman N., Vierkant R.A., Pankratz V.S., and Poland G.A. Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine. Pediatrics 121 5 (2008) e1091-1099
15. Mitchell L.A. Sex differences in antibody- and cell-mediated immune response to rubella re-immunisation. J Med Microbiol 48 12 (1999) 1075-1080
16. Klein N.P., Holmes T.H., Sharp M.A., Heineman T.C., Schleiss M.R., Bernstein D.I., et al. Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adults. Vaccine 24 33-34 (2006) 5913-5918
17. Johnson C.E., Kumar M.L., Whitwell J.K., Staehle B.O., Rome L.P., Dinakar C., et al. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years. Pediatr Infect Dis J 15 8 (1996) 687-692
18. Christenson B., and Bottiger M. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus. Vaccine 12 2 (1994) 129-133
19. Mossong J., O'Callaghan C.J., and Ratnam S. Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population. Vaccine 19 4-5 (2000) 523-529
20. Pebody R.G., Gay N.J., Hesketh L.M., Vyse A., Morgan-Capner P., Brown D.W., et al. Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance. Vaccine 20 7-8 (2002) 1134-1140
21. Manischewitz J., King L.R., Bleckwenn N.A., Shiloach J., Taffs R., Merchlinsky M., et al. Development of a novel vaccinia-neutralization assay based on reporter-gene expression. J Infect Dis 188 3 (2003) 440-448
22. Huber P.J. Robust regression: asymptotics, conjectures and Monte Carlo. Ann Stat 1 5 (1973) 799-821
23. Crotty S., Felgner P., Davies H., Glidewell J., Villarreal L., and Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 171 10 (2003) 4969-4973
24. Belshe R.B., Newman F.K., Frey S.E., Couch R.B., Treanor J.J., Tacket C.O., et al. Dose-dependent neutralizing-antibody responses to vaccinia. J Infect Dis 189 3 (2004) 493-497
25. Combadiere B., Boissonnas A., Carcelain G., Lefranc E., Samri A., Bricaire F., et al. Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans. J Exp Med 199 11 (2004) 1585-1593
26. Mack T.M., Noble Jr. J., and Thomas D.B. A prospective study of serum antibody and protection against smallpox. Am J Trop Med Hyg 21 2 (1972) 214-218
27. Sarkar J.K., Mitra A.C., and Mukherjee M.K. The minimum protective level of antibodies in smallpox. Bull World Health Organ 52 3 (1975) 307-311
28. Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Jacobsen S.J., Pankratz V.S., and Poland G.A. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol 65 12 (2004) 1506-1515
29. Cook I.F. Sexual dimorphism of humoral immunity with human vaccines. Vaccine 26 29-30 (2008) 3551-3555
30. Girón-González J.A., Moral F.J., Elvira J., García-Gil D., Guerrero F., Gavilán I., et al. Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur J Endocrinol 143 1 (2000) 31-36
31. Dixon C.W. Smallpox (1962), J. & A. Churchill, London 512 p.
32. Nyerges G., Hollos I., and Barsy G. The significance of serological tests in controlling the success of smallpox revaccination. Acta Microbiol Acad Sci Hung 13 2 (1966) 97-112
33. Hammarlund E., Lewis M.W., Hansen S.G., Strelow L.I., Nelson J.A., Sexton G.J., et al. Duration of antiviral immunity after smallpox vaccination. Nat Med 9 9 (2003) 1131-1137